These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 8750802)
1. Heparin as a cause of thrombus progression. Heparin-associated thrombocytopenia is an important differential diagnosis in paediatric patients even with normal platelet counts. Klement D; Rammos S; v Kries R; Kirschke W; Kniemeyer HW; Greinacher A Eur J Pediatr; 1996 Jan; 155(1):11-4. PubMed ID: 8750802 [TBL] [Abstract][Full Text] [Related]
2. The use of low dose Orgaran in heparin-induced thrombocytopenia associated with in vitro platelet aggregation at higher Orgaran concentrations. Hill GR; Hickton C; Henderson S; Patton WN Clin Lab Haematol; 1997 Jun; 19(2):155-7. PubMed ID: 9218159 [TBL] [Abstract][Full Text] [Related]
3. [Clinical experience with Danaparoid-sodium: measures to be taken in heparin-induced thrombocytopenia]. Chirurg; 1998 Nov; 69(11 Suppl Massnahme):1-4. PubMed ID: 9853175 [No Abstract] [Full Text] [Related]
4. [Clinical experiences with Danaparoid sodium. Measures to be taken in heparin-induced thrombocytopenia]. Anaesthesist; 1998 Nov; 47(11 Suppl Massnahmen):1-4. PubMed ID: 9884734 [No Abstract] [Full Text] [Related]
5. Danaparoid sodium (Orgaran) in four children with heparin-induced thrombocytopenia type II. Zöhrer' B; Zenz W; Rettenbacher A; Covi P; Kurnik K; Kroll H; Grubbauer HM; Muntean W Acta Paediatr; 2001 Jul; 90(7):765-71. PubMed ID: 11519979 [TBL] [Abstract][Full Text] [Related]
6. Thromboembolic complications in a patient with heparin-induced thrombocytopenia (HIT) showing cross-reactivity to a low molecular weight heparin-treatment with Org 10172 (Lomoparan). Muhm M; Claeys L; Huk I; Koppensteiner R; Kyrle PA; Minar E; Stümpflen A; Ehringer H; Polterauer P Wien Klin Wochenschr; 1997 Feb; 109(4):128-31. PubMed ID: 9076930 [TBL] [Abstract][Full Text] [Related]